58 related articles for article (PubMed ID: 3747756)
1. [Radiation injuries in patients with lymphogranulomatosis in prolonged clinical remission].
Zolotkov AG; Pan'shin GA
Med Radiol (Mosk); 1986 Aug; 31(8):49-53. PubMed ID: 3747756
[TBL] [Abstract][Full Text] [Related]
2. [State of the skin and underlying tissues in late periods following the radiation therapy of lymphogranulomatosis].
Shishkin IP
Med Radiol (Mosk); 1983 Nov; 28(11):12-5. PubMed ID: 6645823
[TBL] [Abstract][Full Text] [Related]
3. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
[TBL] [Abstract][Full Text] [Related]
4. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
5. Long-term (15 years) results of extended field radiotherapy in Hodgkin's disease.
Sevcíková EL; Boljesíková E; Chorváth M; Kovacicová G
Neoplasma; 2000; 47(4):253-6. PubMed ID: 11043832
[TBL] [Abstract][Full Text] [Related]
6. [Radiation reactions and complications in the multipolar betatron irradiation of lymphogranulomatosis patients (split course)].
Fil'kova EM; Zolotkov AG; Pereslegin OI; Salamov RF; Kuternitskaia MF
Med Radiol (Mosk); 1979 May; 24(5):34-9. PubMed ID: 108497
[No Abstract] [Full Text] [Related]
7. Low-dose involved-field radiotherapy as alternative treatment of nodular lymphocyte predominance Hodgkin's lymphoma.
Haas RL; Girinsky T; Aleman BM; Henry-Amar M; de Boer JP; de Jong D
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1199-202. PubMed ID: 19131186
[TBL] [Abstract][Full Text] [Related]
8. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL
Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487
[TBL] [Abstract][Full Text] [Related]
9. Postradiotherapy hypothyroidism: radiation dose response and chemotherapeutic radiosensitization at less than 40 Gy.
Kuten A; Lubochitski R; Fishman G; Dale J; Stein ME
J Surg Oncol; 1996 Apr; 61(4):281-3. PubMed ID: 8627999
[TBL] [Abstract][Full Text] [Related]
10. Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group.
Josting A; Nogová L; Franklin J; Glossmann JP; Eich HT; Sieber M; Schober T; Boettcher HD; Schulz U; Müller RP; Diehl V; Engert A
J Clin Oncol; 2005 Mar; 23(7):1522-9. PubMed ID: 15632410
[TBL] [Abstract][Full Text] [Related]
11. [Thyroid function after external irradiation of the neck in patients with Hodgkin's disease--long-term observation].
Ziora K; Bubała H; Głowacki J; Sońta-Jakimczyk D; Legaszewski T; Zajecki W
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(4):261-7. PubMed ID: 17239303
[TBL] [Abstract][Full Text] [Related]
12. [The 5- and 10-year survival and long-term effects of radical radiotherapy in patients with stage I-III Hodgkin's disease].
Aliev BM; Vasygova NF; Ivanova EM; Kaverzneva MM
Vopr Onkol; 1984; 30(6):41-7. PubMed ID: 6741006
[TBL] [Abstract][Full Text] [Related]
13. Hodgkin's disease. Results from a program in radiation therapy.
Micaily B; Brady LW
Am J Clin Oncol; 1984 Apr; 7(2):159-71. PubMed ID: 6422736
[TBL] [Abstract][Full Text] [Related]
14. [Radiation pericarditis following treatment of lymphogranulomatosis].
Baĭsogolov GD; Shishkin IP; Shapiro IB
Med Radiol (Mosk); 1983 Sep; 28(9):27-31. PubMed ID: 6688649
[TBL] [Abstract][Full Text] [Related]
15. [Radiotherapy in adults with localized supradiaphragmatic stages CS I/II of Hodgkin's disease. 2. The special aspects of radiotherapy: dosage, fractionation, focal volumes, risks, conclusions].
Glanzmann C; Lütolf UM
Strahlenther Onkol; 1993 Oct; 169(10):570-83. PubMed ID: 8235981
[TBL] [Abstract][Full Text] [Related]
16. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
Mjaaland I; Ganser D; Freitag EM; Bohndorf W
Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
[TBL] [Abstract][Full Text] [Related]
17. Calcium status following neck radiation therapy in Hodgkin's disease.
Nader S; Schultz PN; Fuller LM; Samaan NA
Arch Intern Med; 1984 Aug; 144(8):1577-8. PubMed ID: 6466016
[TBL] [Abstract][Full Text] [Related]
18. Value of radiation therapy in the management of chemoresistant intermediate grade non-Hodgkin's lymphoma.
Aref A; Narayan S; Tekyi-Mensah S; Varterasian M; Dan M; Eilender D; Karanes C; al-Katib A
Radiat Oncol Investig; 1999; 7(3):186-91. PubMed ID: 10406061
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
De Bruin ML; Sparidans J; van't Veer MB; Noordijk EM; Louwman MW; Zijlstra JM; van den Berg H; Russell NS; Broeks A; Baaijens MH; Aleman BM; van Leeuwen FE
J Clin Oncol; 2009 Sep; 27(26):4239-46. PubMed ID: 19667275
[TBL] [Abstract][Full Text] [Related]
20. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications.
Koontz BF; Kirkpatrick JP; Clough RW; Prosnitz RG; Gockerman JP; Moore JO; Prosnitz LR
J Clin Oncol; 2006 Feb; 24(4):605-11. PubMed ID: 16446333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
